DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis

Abstract

Pancreatic ductal adenocarcinoma (PDAC) tumors are characterized by a desmoplastic reaction resulting in dense deposition of collagen that is known to promote cancer progression. A central mediator of protumorigenic collagen signaling is the receptor tyrosine kinase discoid domain receptor 1 (DDR1). DDR1 is a critical driver of a mesenchymal and invasive cancer cell PDAC phenotype. Previous studies have demonstrated that genetic or pharmacologic inhibition of DDR1 reduces PDAC tumorigenesis and metastasis. Here, we investigated whether DDR1 signaling has cancer cell nonautonomous effects that promote PDAC progression and metastasis. We demonstrate that collagen-induced DDR1 activation in cancer cells is a major stimulus for CXCL5 production, resulting in the recruitment of tumor-associated neutrophils (TANs), the formation of neutrophil extracellular traps (NETs), and subsequent cancer cell invasion and metastasis. Moreover, we have identified that collagen-induced CXCL5 production was mediated by a DDR1/PKC θ /SYK/NF- κ B signaling cascade. Together, these results highlight the critical contribution of the collagen I–DDR1 interaction in the formation of an immune microenvironment that promotes PDAC metastasis.

References 66

1. 1.

   Neoptolemos JP, et al. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol. 2018;15(6):333-348.

   Not in our library10.1038/s41575-018-0005-x (opens in a new tab)

2. 2.

   Rahib L, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913-2921.

   Not in our library10.1158/0008-5472.can-14-0155 (opens in a new tab)

3. 3.

   Hosein AN, et al. Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat Rev Gastroenterol Hepatol. 2020;17(8):487-505.

   Not in our library10.1038/s41575-020-0300-1 (opens in a new tab)

4. 4.

   Huang H, et al. Extracellular matrix induction of intracellular reactive oxygen species. Antioxid Redox Signal. 2017;27(12):774-784.

   Not in our library10.1089/ars.2017.7305 (opens in a new tab)

5. 5.

   Huang H, et al. Getting a grip on adhesion: cadherin switching and collagen signaling. Biochim Biophys Acta Mol Cell Res. 2019;1866(11):118472.

   Not in our library10.1016/j.bbamcr.2019.04.002 (opens in a new tab)

6. 6.

   Leitinger B. Discoidin domain receptor functions in physiological and pathological conditions. Int Rev Cell Mol Biol. 2014;310:39-87.

   Not in our library10.1016/b978-0-12-800180-6.00002-5 (opens in a new tab)

7. 7.

   Valiathan RR, et al. Discoidin domain receptor tyrosine kinases: new players in cancer progression. Cancer Metastasis Rev. 2012;31(1–2):295-321.

   Not in our library10.1007/s10555-012-9346-z (opens in a new tab)

8. 8.

   Huo Y, et al. High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res. 2015;34:88.

   Not in our library10.1186/s13046-015-0202-1 (opens in a new tab)

9. 9.

   Shintani Y, et al. Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. J Cell Biol. 2008;180(6):1277-1289.

   Not in our library10.1083/jcb.200708137 (opens in a new tab)

10. 10.

    Huang H, et al. Up-regulation of N-cadherin by collagen I-activated discoidin domain receptor 1 in pancreatic cancer requires the adaptor molecule Shc1. J Biol Chem. 2016;291(44):23208-23223.

    Not in our library10.1074/jbc.m116.740605 (opens in a new tab)

11. 11.

    Ruggeri JM, et al. Discoidin domain receptor 1 (DDR1) is necessary for tissue homeostasis in pancreatic injury and pathogenesis of pancreatic ductal adenocarcinoma. Am J Pathol. 2020;190(8):1735-1751.

    Not in our library10.1016/j.ajpath.2020.03.020 (opens in a new tab)

12. 12.

    Aguilera KY, et al. Inhibition of discoidin domain receptor 1 reduces collagen-mediated tumorigenicity in pancreatic ductal adenocarcinoma. Mol Cancer Ther. 2017;16(11):2473-2485.

    Not in our library10.1158/1535-7163.mct-16-0834 (opens in a new tab)

13. 13.

    Lambert AW, et al. Emerging biological principles of metastasis. Cell. 2017;168(4):670-691.

    Not in our library10.1016/j.cell.2016.11.037 (opens in a new tab)

14. 14.
    Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment · 2016

    No notice
15. 15.

    Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13(3):159-175.

    Not in our library10.1038/nri3399 (opens in a new tab)

16. 16.

    Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18(2):134-147.

    Not in our library10.1038/nri.2017.105 (opens in a new tab)

17. 17.

    Cedervall J, Olsson AK. Immunity gone astray — NETs in cancer. Trends Cancer. 2016;2(11):633-634.

    Not in our library10.1016/j.trecan.2016.10.012 (opens in a new tab)

18. 18.

    Tohme S, et al. Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress. Cancer Res. 2016;76(6):1367-1380.

    Not in our library10.1158/0008-5472.can-15-1591 (opens in a new tab)

19. 19.

    Cools-Lartigue J, et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest.

    Not in our library10.1172/jci67484 (opens in a new tab)

20. 20.

    Albrengues J, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018;361(6409):eaao4227.

    Not in our library10.1126/science.aao4227 (opens in a new tab)

21. 21.

    Park J, et al. Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci Transl Med. 2016;8(361):361ra138.

    Not in our library10.1126/scitranslmed.aag1711 (opens in a new tab)

22. 22.

    Yang L, et al. DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25. Nature. 2020;583(7814):133-138.

    Not in our library10.1038/s41586-020-2394-6 (opens in a new tab)

23. 23.

    Boone BA, et al. The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer. Cancer Gene Ther. 2015;22(6):326-334.

    Not in our library10.1038/cgt.2015.21 (opens in a new tab)

24. 24.

    Demers M, Wagner DD. Neutrophil extracellular traps: a new link to cancer-associated thrombosis and potential implications for tumor progression. Oncoimmunology. 2013;2(2):e22946.

    Not in our library10.4161/onci.22946 (opens in a new tab)

25. 25.

    Miller-Ocuin JL, et al. DNA released from neutrophil extracellular traps (NETs) activates pancreatic stellate cells and enhances pancreatic tumor growth. Oncoimmunology. 2019;8(9):e1605822.

    Not in our library10.1080/2162402x.2019.1605822 (opens in a new tab)

26. 26.

    Sivanandham R, et al. Neutrophil extracellular trap production contributes to pathogenesis in SIV-infected nonhuman primates. J Clin Invest. 2018;128(11):5178-5183.

    Not in our library10.1172/jci99420 (opens in a new tab)

27. 27.

    Li X, et al. Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery. Clin Cancer Res. 2014;20(24):6529-6540.

    Not in our library10.1158/1078-0432.ccr-14-0970 (opens in a new tab)

28. 28.

    Zhou SL, et al. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology. 2012;56(6):2242-2254.

    Not in our library10.1002/hep.25907 (opens in a new tab)

29. 29.

    Papayannopoulos V, et al. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol. 2010;191(3):677-691.

    Not in our library10.1083/jcb.201006052 (opens in a new tab)

30. 30.

    Li P, et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med. 2010;207(9):1853-1862.

    Not in our library10.1084/jem.20100239 (opens in a new tab)

31. 31.

    Brinkmann V, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532-1535.

    Not in our library10.1126/science.1092385 (opens in a new tab)

32. 32.

    Roca H, et al. Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone. J Clin Invest. 2018;128(1):248-266.

    Not in our library10.1172/jci92466 (opens in a new tab)

33. 33.

    Das S, et al. Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-kappaB pathway activation. Cancer Res. 2006;66(16):8123-8130.

    Not in our library10.1158/0008-5472.can-06-1215 (opens in a new tab)

34. 34.

    Luangdilok S, et al. Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck. Cancer Res. 2007;67(16):7907-7916.

    Not in our library10.1158/0008-5472.can-07-0331 (opens in a new tab)

35. 35.

    Ghotra VP, et al. SYK is a candidate kinase target for the treatment of advanced prostate cancer. Cancer Res. 2015;75(1):230-240.

    Not in our library10.1158/0008-5472.can-14-0629 (opens in a new tab)

36. 36.

    Yuge R, et al. Silencing of discoidin domain receptor-1 (DDR1) concurrently inhibits multiple steps of metastasis cascade in gastric cancer. Transl Oncol. 2018;11(3):575-584.

    Not in our library10.1016/j.tranon.2018.02.003 (opens in a new tab)

37. 37.
    Extracellular traps derived from macrophages, mast cells, eosinophils and neutrophils are generated in a time‐dependent manner during atherothrombosis · 2019

    No notice
38. 38.

    Teijeira Á, et al. CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity. Immunity. 2020;52(5):856-871.e8.

    Not in our library10.1016/j.immuni.2020.03.001 (opens in a new tab)

39. 39.

    Cedervall J, et al. Neutrophil extracellular traps accumulate in peripheral blood vessels and compromise organ function in tumor-bearing animals. Cancer Res. 2015;75(13):2653-2662.

    Not in our library10.1158/0008-5472.can-14-3299 (opens in a new tab)

40. 40.

    Li A, et al. Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer. Am J Pathol. 2011;178(3):1340-1349.

    Not in our library10.1016/j.ajpath.2010.11.058 (opens in a new tab)

41. 41.

    Kawamura M, et al. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer. Eur J Cancer. 2012;48(14):2244-2251.

    Not in our library10.1016/j.ejca.2011.11.032 (opens in a new tab)

42. 42.

    Zhou SL, et al. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. Cancer Lett. 2015;358(2):124-135.

    Not in our library10.1016/j.canlet.2014.11.044 (opens in a new tab)

43. 43.

    Seo MC, et al. Discoidin domain receptor 1 mediates collagen-induced inflammatory activation of microglia in culture. J Neurosci Res. 2008;86(5):1087-1095.

    Not in our library10.1002/jnr.21552 (opens in a new tab)

44. 44.

    Gao H, et al. Multi-organ site metastatic reactivation mediated by non-canonical discoidin domain receptor 1 signaling. Cell. 2016;166(1):47-62.

    Not in our library10.1016/j.cell.2016.06.009 (opens in a new tab)

45. 45.
    Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches · 2016

    No notice
46. 46.

    Karin M. NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol. 2009;1(5):a000141.

    Not in our library10.1101/cshperspect.a000141 (opens in a new tab)

47. 47.

    Zafar A, et al. Chromatinized protein kinase C-θ directly regulates inducible genes in epithelial to mesenchymal transition and breast cancer stem cells. Mol Cell Biol. 2014;34(16):2961-2980.

    Not in our library10.1128/mcb.01693-13 (opens in a new tab)

48. 48.

    Sokolova O, et al. Protein kinase C isozymes regulate matrix metalloproteinase-1 expression and cell invasion in Helicobacter pylori infection. Gut. 2013;62(3):358-367.

    Not in our library10.1136/gutjnl-2012-302103 (opens in a new tab)

49. 49.

    Bailey P, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531(7592):47-52.

    Not in our library10.1038/nature16965 (opens in a new tab)

50. 50.

    Lesina M, et al. RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis. J Clin Invest. 2016;126(8):2919-2932.

    Not in our library10.1172/jci86477 (opens in a new tab)

51. 51.

    Mizukami Y, et al. Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Nat Med. 2005;11(9):992-997.

    Not in our library10.1038/nm1294 (opens in a new tab)

52. 52.

    Ancrile B, et al. Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev. 2007;21(14):1714-1719.

    Not in our library10.1101/gad.1549407 (opens in a new tab)

53. 53.

    Ling J, et al. KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;21(1):105-120.

    Not in our library10.1016/j.ccr.2011.12.006 (opens in a new tab)

54. 54.

    Deer EL, et al. Phenotype and genotype of pancreatic cancer cell lines. Pancreas. 2010;39(4):425-435.

    Not in our library10.1097/mpa.0b013e3181c15963 (opens in a new tab)

55. 55.

    Guo S, Deng CX. Effect of stromal cells in tumor microenvironment on metastasis initiation. Int J Biol Sci. 2018;14(14):2083-2093.

    Not in our library10.7150/ijbs.25720 (opens in a new tab)

56. 56.

    Cerami E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401-404.

    Not in our library10.1158/2159-8290.cd-12-0095 (opens in a new tab)

57. 57.

    Beltran H, et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat Med. 2016;22(3):298-305.

    Not in our library10.1038/nm.4045 (opens in a new tab)

58. 58.

    Ambrogio C, et al. Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma. Nat Med. 2016;22(3):270-277.

    Not in our library10.1038/nm.4041 (opens in a new tab)

59. 59.

    Cespedes MV, et al. Selective depletion of metastatic stem cells as therapy for human colorectal cancer. EMBO Mol Med. 2018;10(10):e8772.

    Not in our library10.15252/emmm.201708772 (opens in a new tab)

60. 60.

    Gao M, et al. Discovery and optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as novel selective and orally bioavailable discoidin domain receptor 1 (DDR1) inhibitors. J Med Chem. 2013;56(8):3281-3295.

    Not in our library10.1021/jm301824k (opens in a new tab)

61. 61.

    Geller LT, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357(6356):1156-1160.

    Not in our library10.1126/science.aah5043 (opens in a new tab)

62. 62.

    Smith TJ, et al. Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice guideline update. J Clin Oncol. 2015;33(28):3199-3212.

    Not in our library10.1200/jco.2015.62.3488 (opens in a new tab)

63. 63.

    Kim MP, et al. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nat Protoc. 2009;4(11):1670-1680.

    Not in our library10.1038/nprot.2009.171 (opens in a new tab)

64. 64.
    Neutrophil Isolation Protocol · 2008

    No notice
65. 65.

    Chou RH, et al. EGFR modulates DNA synthesis and repair through Tyr phosphorylation of histone H4. Dev Cell. 2014;30(2):224-237.

    Not in our library10.1016/j.devcel.2014.06.008 (opens in a new tab)

66. 66.

    Milne TA, et al. Chromatin immunoprecipitation (ChIP) for analysis of histone modifications and chromatin-associated proteins. Methods Mol Biol. 2009;538:409-423.

    Not in our library10.1007/978-1-59745-418-6_21 (opens in a new tab)

Cited by papers we hold 4

• Neutrophil extracellular traps in homeostasis and disease · 2024
  No notice
• Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives · 2024
  No notice
• The Collagen Receptor Discoidin Domain Receptor 1b Enhances Integrin β1-Mediated Cell Migration by Interacting With Talin and Promoting Rac1 Activation · 2022
  Not checked
• Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome · 2022
  Corrected

Questions about this paper

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.